Tahj Williams became the first local artist to create the Super Bowl logo ahead of the 2025 championship game. Here's what to know about her design.

What do you think of when you see a swooping black checkmark, a yellow shell on a red background, or a multi-colored letter G ...

They say beauty is in the eye of the beholder, but it helps if the object of your gaze is symmetrical. Studies show humans associate symmetry with attractivenes ...

OpenAI's o1 reasoning model usually requires a costly subscription, but it's now free to all Microsoft Copilot users. This ...

‘The edit is screaming a Linda banishment tonight,’ viewer Dylan wrote on X, immediately after that scene aired. ‘Oh my god THAT EDIT,’ @MrsGMusicTeach wrote. And Minah did end up turning ...

The best free video ... tried video editing before, it’s a strong place to start. But there’s multi-track support for more complex projects. Clipchamp’s real magic is in its templates.

Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu from Wells Fargo maintained a Hold rating on the ...

The treatment, which uses base editing to make a single-letter change in DNA, reduced levels of the disease-causing prion protein in the brain by as much as 60 percent.

The Los Angeles Rams rolled over the Minnesota Vikings in Monday's wild-card playoff finale. They did lose a key offensive player, however, with tight end Tyler Higbee exiting the matchup in the ...

and makes them free and easy to use on a mobile app. There's a whole generation of editors who started with CapCut before they made the jump to more traditional editing software. Removing the app ...

This feature, entering beta, will integrate InDesign APIs with various data sources, allowing companies to arrange text and images into templates ... tedious aspects of editing pictures on a ...

The company’s innovative approach using the Axiomer RNA editing platform to address this genetic driver is promising, with plans to commence clinical testing of their PNPLA3-targeted candidate ...